Dynavax Technologies
DVAX
#4921
Rank
C$2.60 B
Marketcap
C$22.23
Share price
0.00%
Change (1 day)
12.58%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -C$51.98 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are C$0.33 Billion. In 2024 the company made an earning of C$53.98 Million, an increase over its 2023 earnings that were of C$3.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$51.98 Million-196.27%
2024 C$53.98 M1475.31%
2023 C$3.42 M-99.2%
2022 C$0.43 B238.78%
2021 C$0.12 B-257.89%
2020 -C$80.56 Million-58.58%
2019 -C$0.2 Billion-9.32%
2018 -C$0.22 Billion60.44%
2017 -C$0.14 Billion-15.8%
2016 -C$0.16 Billion4.22%
2015 -C$0.16 Billion16.54%
2014 -C$0.14 Billion37.09%
2013 -C$95.34 Million
2010 -C$68.24 Million214.85%
2009 -C$21.68 Million-37.33%
2008 -C$34.59 Million-66.07%
2007 -C$0.11 Billion16.92%
2006 -C$87.19 Million170.36%
2005 -C$32.25 Million33.39%
2004 -C$24.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.99 B-20,661.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.84 B-32,713.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$0.63 B-1,413.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$3.64 Billion 7,374.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.64 B-19,938.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$21.63 B-44,626.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$10.25 B-21,212.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
C$0.21 B-545.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.75 B-3,711.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel